ATC Virtual Abstracts #2
Future of Telemedicine and COVID Insights
Future of Telemedicine and COVID Insights
Sureshkumar – Impact of kidney transplant type and previous transplant on baseline donor‐derived cell…
ATC Symposium
ATC Virtual Abstracts #1
2020 HLA Webinar Series #3: Meet-The-Expert – AlloSeq Assign: Advanced Options and Difficult Samples
Overcoming COVID: Transplant Patient Patrick Gee Shares His Story
Ramsey – Genomic Biomarker Surveillance in the Care of Solid Organ Transplant Recipients: An Update for…
Abdolreza Haririan, MD, MPH, Univ. of Maryland -Characterization of an Integrative Prognostic Score (iBox)…
Kalathil Sureshkumar, MD, Allegheny Health Network – Impact of Kidney Transplant Type and Previous…
D.J. Levine, MD, UT Health San Antonio – A Single Center Snapshot Experience with %dd-cf-DNA in Lung…
Yasir Qazi, MD, USC – Role of Cell Free DNA (AlloSure) Testing in Recipients of Kidneys with Sub…
Erik Stites, MD, UC Health – Utility of dd-cfDNA in TCMR1a and Borderline Allograft Rejection
Dechu Puliyanda, MD, Cedars-Sinai – Use of a Donor-derived Cell-Free DNA Assay to Monitor Treatment…
Anthony Langone, MD, Vanderbilt – Value of dd-cfDNA when Considering Recipient Ethnicity to Further…
Velma Scantlebury, MD, ChristianaCare – The Use of AlloSure Donor Derived Cell-Free DNA in a Community…
Levine – Single Center Snapshot Experience of dd-cfDNA in Lung Transplantation
Holzhause – The Journal of Heart and Lung Transplantation – Donor derived cell free DNA is…
Holzhause – The Journal of Heart and Lung Transplantation – Donor derived cell free DNA is…
Lipson – Kidney retransplantation after anti–programmed cell death‐1 (PD‐1)–related allograft…
Stites – High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at…
Grskovic – Performance of Donor-derived Cell-free DNA Assays in Kidney Transplant Patients
Loupy – Prediction system for risk of allograft loss in patients receiving kidney transplants:…